Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Nov 16, 2021 9:19am
92 Views
Post# 34131003

Trust issues + Pandemic to be over Jan 4, 2022 per Pfizer

Trust issues + Pandemic to be over Jan 4, 2022 per PfizerI think that there will be no rally or very little move for the following reasons:

(a)  Severe Trust issues 

(b)  Pandemic to stop Jan 4, 2022 per Pfizer so results not sustainable

(c)  Avalanche of 180 million shares that need to be sold

(d)  Reverse stock split of 1 for 15 shares

(e) Inability to pay debts despite record sales

(f)  Bloated accounts payable of $ 20,500,000

(g) No shift to telemedicine to speak of as company still focused on testing 

(h) Biden lost appeal so no forced vaccines or testing (huge letdown)


We open 5.5 cents and stay there as no one is fooled by the results.

My personal opinion, 




<< Previous
Bullboard Posts
Next >>